Ironwood Pharmaceuticals reported $2.21M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US $ 42.61M 247K
Ardelyx ARDX:US $ 0.79M 0.04M
Charles River Laboratories CRL:US $ 3.7M 5.73M
Emergent Biosolutions EBS:US $ 7.8M 0.4M
Esperion Therapeutics ESPR:US $ 14.27M 204K
Exact Sciences EXAS:US $ 4.51M 0.03M
Halozyme Therapeutics HALO:US $ 3.1M 1.34M
Intercept Pharmaceuticals ICPT:US $ 6.67M 0M
Ironwood Pharmaceuticals IRWD:US $ 2.21M 0.13M
Karyopharm Therapeutics KPTI:US $ 6.31M 371K
Lexicon Pharmaceuticals LXRX:US 703K 593K
Moderna Inc MRNA:US 5M 1000K
Myriad Genetics MYGN:US $ 0.6M 0.3M
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Ptc Therapeutics PTCT:US $ 22.28M 1.34M
Puma Biotechnology PBYI:US $ 2.7M 0.04M
Sarepta Therapeutics SRPT:US $ 16.03M 0.23M
YTE INCY:US $ 0.68M 0M